BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Bio-path Holdings Inc.

Headquarters: Bellaire, TX, United States
Year Founded: 2007
Status: Public
Industry Sector: HealthTechnology
CEO: Peter H. Nielsen, MBA
Number Of Employees: 10
Enterprise Value: $1,695,160
PE Ratio: -0.02
Exchange/Ticker 1: NASDAQ:BPTH
Exchange/Ticker 2: N/A
Latest Market Cap: $1,354,200

BioCentury | Nov 4, 2016
Clinical News

BP1001: Ph II started

BioCentury | Jul 18, 2016
Company News

Bio-Path, Thomas Jefferson University deal

BioCentury | Jul 11, 2016
Financial News

Bio-Path proposes direct public offering

BioCentury | Jun 13, 2016
Clinical News

Liposomal Grb-2: Additional Phase I data

BioCentury | Sep 7, 2015
Clinical News

Liposomal Grb-2: Phase I data

BioCentury | May 4, 2015
Clinical News

Liposomal Grb-2 regulatory update

BioCentury | Feb 16, 2015
Clinical News

Liposomal Grb-2: Phase II started

BioCentury | Apr 7, 2014
Company News

Bio-Path management update

BioCentury | Mar 17, 2014
Financial News

Bio-Path financial update

Items per page:
1 - 10 of 18